Physician profile
Barbara L Hoffer
NPI 1700237054
$467.56
in general payments reported to CMS, 2019-2025
16 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.13 · 2022: $22.44 · 2024: $204 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $80.70 | 2024-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $55.93 | 2024 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $47.28 | 2024-2025 | Tezspire, Airsupra |
| Abbvie INC. | $37.11 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $33.32 | 2025 | Dupixent |
| United Therapeutics Corporation | $28.90 | 2024 | Tyvaso |
| Harmony Biosciences LLC | $27.08 | 2025 | |
| Sientra, INC. | $22.44 | 2022 | |
| Ani Pharmaceuticals, INC. | $20.72 | 2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $20.13 | 2021 | |
| Merck Sharp & Dohme LLC | $19.69 | 2024 | Pifeltro, Delstrigo |
| Jazz Pharmaceuticals INC. | $17.80 | 2025 | |
| Lilly USA, LLC | $15.96 | 2024 | Omvoh, Zepbound |
| Qol Medical, LLC | $14.89 | 2024 | Sucraid |
| Viatris Specialty LLC | $13.72 | 2025 | Yupelri |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $11.89 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Hoffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.